PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Picard Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$15.45+2.70 (+21.18%)

Close on Oct 19, 2026

Market cap: $28.67M
P/E (TTM): –
Dividend yield: –

SEC filings

40 of Picard Medical's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Oct 7, 2026	Oct 13, 2026	SEC EDGAR
Current report	8-K	Sep 30, 2026	Oct 6, 2026	SEC EDGAR
Current report	8-K	Aug 19, 2026	Aug 20, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 19, 2026	SEC EDGAR
Current report	8-K	Jul 22, 2026	Jul 27, 2026	SEC EDGAR
Current report	8-K	Jul 21, 2026	Jul 22, 2026	SEC EDGAR
Current report	8-K	Jul 17, 2026	Jul 21, 2026	SEC EDGAR
Current report	8-K	Jul 2, 2026	Jul 2, 2026	SEC EDGAR
Current report	8-K	Jul 2, 2026	Jul 2, 2026	SEC EDGAR
Current report	8-K	Jun 23, 2026	Jun 29, 2026	SEC EDGAR
Proxy statement	DEF 14A	Jul 17, 2026	Jun 29, 2026	SEC EDGAR
Current report	8-K	Jun 18, 2026	Jun 24, 2026	SEC EDGAR
Current report	8-K	Jun 1, 2026	Jun 2, 2026	SEC EDGAR
Current report	8-K	May 29, 2026	May 29, 2026	SEC EDGAR
Current report	8-K	May 15, 2026	May 21, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 15, 2026	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2025	May 15, 2026	SEC EDGAR
Current report	8-K	May 5, 2026	May 11, 2026	SEC EDGAR
Current report	8-K	May 5, 2026	May 5, 2026	SEC EDGAR
Current report	8-K	Apr 22, 2026	Apr 22, 2026	SEC EDGAR
Current report	8-K	Apr 7, 2026	Apr 13, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 30, 2026	SEC EDGAR
Current report	8-K	Mar 25, 2026	Mar 27, 2026	SEC EDGAR
Current report	8-K	Mar 25, 2026	Mar 25, 2026	SEC EDGAR
Current report	8-K	Mar 20, 2026	Mar 20, 2026	SEC EDGAR
Current report	8-K	Mar 19, 2026	Mar 19, 2026	SEC EDGAR
Current report	8-K	Mar 17, 2026	Mar 17, 2026	SEC EDGAR
Current report	8-K	Mar 10, 2026	Mar 16, 2026	SEC EDGAR
Current report	8-K	Mar 13, 2026	Mar 13, 2026	SEC EDGAR
Current report	8-K	Mar 12, 2026	Mar 13, 2026	SEC EDGAR
Current report	8-K	Mar 2, 2026	Mar 2, 2026	SEC EDGAR
Current report	8-K	Feb 26, 2026	Feb 26, 2026	SEC EDGAR
Proxy statement	DEF 14A	Mar 10, 2026	Feb 19, 2026	SEC EDGAR
Current report	8-K	Jan 13, 2026	Jan 13, 2026	SEC EDGAR
Current report	8-K	Jan 13, 2026	Jan 13, 2026	SEC EDGAR
Current report	8-K	Dec 24, 2025	Dec 30, 2025	SEC EDGAR
Current report	8-K	Dec 18, 2025	Dec 18, 2025	SEC EDGAR
Current report	8-K	Dec 9, 2025	Dec 9, 2025	SEC EDGAR
Current report	8-K	Dec 4, 2025	Dec 4, 2025	SEC EDGAR
Current report	8-K	Dec 3, 2025	Dec 3, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Picard Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-50 reverse split on Aug 3, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PMI.

Revenue growth41.0% · median 33.4%

Gross margin18.6% · median 18.1%

Operating margin-248.1% · median -364.8%

Net margin-444.3% · median -435.7%

Company	Revenue	Growth
BTCY	$16.40M	+13.4%
NSPR	$10.84M	+53.4%
MDNC	$10.21M	-10.9%
XAIR	$7.69M	+60.7%
NONE.	$6.45M	–
PMI	$6.30M	+41.0%

Company

Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 75
Auditor: MaloneBailey, LLP
SEC CIK: 2030617

Advertisement
300 × 250